AGP Picks
View all

Healthcare Focus Montserrat: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Montserrat.

Press releases published on August 4, 2026

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
Pacira BioSciences Reports Second Quarter 2026 Financial Results
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update
Applied Biologics Marks 10 Years of Continuous AATB Accreditation While Initiating Reaccreditation Process
Pennant Acquires River Centre Assisted Living in Tucson, Arizona 
Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11
More Than A (Gut) Feeling: Americans Agree Gut Health Matters, But Not On What It Means
FSR Invests $700,000 Across Four Sarcoidosis Studies to Improve Diagnosis, Monitoring, and Patient Outcomes
ClinNEXUS Appoints John Stamatopoulos to New Position of Chief Growth Officer
Trans Canada Trail’s Great Canadian Hike returns with 100,000-kilometre challenge
FixMold Miami Named South Florida's #1 Mold Assessment and Mold Remediation Company After Surpassing 6,500 Annual Mold Assessments and 2,000 Remediation Projects
Advocates and Bipartisan Lawmakers Rally at California State Capitol in Support of a Lesser-Known Form of Dementia
EmblemHealth and NewYork-Presbyterian Reach New Agreement
Technology is Transforming Rural Healthcare — and Putting Patients at the Center
Parker University Alumni and Student Earn Top Honors, Assume Leadership Roles in Texas Chiropractic Association
Molecure erhält positive Empfehlung des IDMC zur Fortsetzung der klinischen Studie „KITE“ ohne Änderungen am Prüfplan (Entwicklungsprogramm OATD-01)
Molecure reçoit une recommandation favorable de l’IDMC pour poursuivre l’essai clinique KITE sans modification du protocole de l’étude (programme de développement OATD-01)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Focus Montserrat

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.